Serina Therapeutics (SER) Operating Expenses (2018 - 2026)
Serina Therapeutics (SER) posted Operating Expenses of $6.2 million for Q4 2025, down 2.89% sequentially from $6.4 million in Q3 2025, and up 12.14% YoY from $5.5 million in Q4 2024.
Serina Therapeutics (SER) Operating Expenses (2018 - 2026) Analysis & Trends
Serina Therapeutics has reported Operating Expenses for 8 years, with the latest figure at $6.2 million in Q4 2025.
- Quarterly Operating Expenses rose 12.14% year-over-year to $6.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $24.2 million (up 41.21% YoY) and the FY2025 annual result came in at $24.2 million, up 41.21% from the prior year.
- Operating Expenses eased to $6.2 million in Q4 2025 per SER's latest filing, from $6.4 million in the prior quarter.
- Over five years, Operating Expenses peaked at $6.4 million in Q3 2025 and troughed at $952000.0 in Q2 2023.
- A 5-year average of $3.1 million and a median of $2.3 million in 2021 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2023 and 2024: Operating Expenses tumbled 51.75% in 2023, then jumped 311.45% in 2024.
- Over 5 years, Operating Expenses stood at $1.9 million in 2021, then dropped by 5.49% to $1.8 million in 2022, then soared by 59.08% to $2.8 million in 2023, then surged by 94.48% to $5.5 million in 2024, then climbed by 12.14% to $6.2 million in 2025.
- According to Business Quant data, Operating Expenses over the past three periods registered $6.2 million, $6.4 million, and $5.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.06 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 427.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 541.02 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -784.57 Mn |
| 10 | Serina Therapeutics | 43.17 Mn | 20.15 Mn | - | 6.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.78 Mn |
| Dec 31, 2025 | 6.21 Mn |
| Sep 30, 2025 | 6.39 Mn |
| Jun 30, 2025 | 5.70 Mn |
| Mar 31, 2025 | 5.86 Mn |
| Dec 31, 2024 | 5.54 Mn |
| Sep 30, 2024 | 5.33 Mn |
| Jun 30, 2024 | 3.92 Mn |
| Mar 31, 2024 | 2.33 Mn |
| Dec 31, 2023 | 2.85 Mn |
| Sep 30, 2023 | 1.49 Mn |
| Jun 30, 2023 | 952,000.00 |
| Mar 31, 2023 | 992,000.00 |
| Dec 31, 2022 | 1.79 Mn |
| Sep 30, 2022 | 1.55 Mn |
| Jun 30, 2022 | 1.60 Mn |
| Mar 31, 2022 | 2.06 Mn |
| Dec 31, 2021 | 1.89 Mn |
| Sep 30, 2021 | 1.70 Mn |
| Jun 30, 2021 | 2.23 Mn |